Atropos funding surge enhancing AI in healthcare
Atropos Health announced last week the successful completion of its $33 million Series B funding round.
Stay updated with breaking news from Mike Spadafore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Atropos Health announced last week the successful completion of its $33 million Series B funding round.
The startup is focused on building out strategic partnerships with pharmaceutical companies and vertically integrated healthcare companies.
Atropos Health raises $33M on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions,
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Providers who don't take advantage of AI will get "left behind," said Dr. Shantanu Gaur, founder and CEO of Allurion Technologies, during a panel discussion at INVEST Digital Health.